RAPT Q2 2021 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$869,000-31.9% YoY

Gross Profit

$869,000100.0% margin

Operating Income

-$16M-1850.5% margin

Net Income

-$16M-1853.9% margin

EPS (Diluted)

$-5.04

QoQ Revenue Growth

-28.9%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$231M

Total Liabilities

$14M

Stockholders' Equity

$218M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$869,000	$1M	-31.9%
Gross Profit	$869,000	$1M	-31.9%
Operating Income	-$16M	-$13M	-28.5%
Net Income	-$16M	-$12M	-30.1%